You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 62 No. 4, October 1950 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

PODOPHYLLIN IN THE TREATMENT OF CUTANEOUS CARCINOMA

ARTHUR B. KERN, M.D.; HERBERT FANGER, M.D.

Arch Derm Syphilol. 1950;62(4):526-532.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

PODOPHYLLIN (resin of podophyllum N.F.), an extract of the dried rhizome and roots of the May apple, or mandrake, has been employed for more than one hundred years as a laxative and more recently as a supposed liver stimulant. In 1942, Kaplan1 reported successful results in the treatment of condyloma acuminatum with topical application of a 25 per cent suspension of podophyllin in liquid petrolatum.

The rapid involution of the condylomas was assumed by Culp and Kaplan2 to be due to spasm of the small vessels induced by the irritant action of the drug, with resultant ischemia and necrosis. However, the histologic studies of treated lesions by Sullivan and King3 suggested a different mode of action. They found that 24 to 48 hours after application of podophyllin the epidermis showed two types of change: superficially there was loss of intercellular bridges with accentuation . . . [Full Text PDF of this Article]


Author Affiliations

PROVIDENCE, R. I.

From the Department of Dermatology, dermatologist in chief, Dr. Francesco Ronchese; Department of Pathology, director, Dr. Herbert Fanger, and Tumor Clinic of the Rhode Island Hospital.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1950 American Medical Association. All Rights Reserved.